Skip to content

Orsiro 4.0/15/140

by Biotronik, Inc.

Orsiro 4.0/15/140 (401746), a drug-eluting coronary artery stent (FDA Class III; FDA product code NIQ, Coronary drug-eluting stent) made by Biotronik, Inc., was listed in FDA GUDID on 26 Feb 2019 (UDI-DI 07640130439016); the registry lists it as not in commercial distribution (GUDID) as of 23 Oct 2026.

Listed FDA GUDID listing, not in commercial distribution

Valid until

Not applicable

Database listing, no authorization

FDA recalls

Not checked

No FDA submission to match recalls against

Documents

None

No authorization documents

Trust

Unverified

Source GUDID, synced 23 Oct 2026.

Regulatory status

as of registry sync 23 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesGUDID listing Number07640130439016 UDI-DI Date26 Feb 2019ListedStatusListed GUDID: not in commercial distribution

Official records

From the FDA record

MRI safety
MR Conditional
Natural rubber latex
No latex statement on the label
Sterility
Supplied sterile

From the GUDID record (AccessGUDID), as read on 23 Oct 2026, as the labeller entered it.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — GUDID listing Listed

Specification

GUDID

Trade name
Orsiro
Generic name
Drug-eluting coronary artery stent, bioabsorbable-polymer-coated
Model / Ref / Catalog
4.0/15/140, 401746
Primary DI / UDI-DI
07640130439016
FDA product code
NIQ
GMDN term
Drug-eluting coronary artery stent, bioabsorbable-polymer-coated
Device class
Class III
GUDID distribution status
Not in Commercial Distribution
MRI safety
MR Conditional

Similar devices

Other devices filed under FDA product code NIQ (Coronary drug-eluting stent).

Other devices from Biotronik, Inc.

See all devices from Biotronik, Inc. →

Properties

  • Supplied sterile
  • Single use
  • Implantable
  • Prescription use
  • Combination product
  • Lot / batch number
  • Expiration date
Other properties (8, all answered No)